Published in Transpl Int on September 14, 2015
The promise of organ and tissue preservation to transform medicine. Nat Biotechnol (2017) 0.80
Decellularized skin/adipose tissue flap matrix for engineering vascularized composite soft tissue flaps. Acta Biomater (2016) 0.76
Accommodation and related conditions in vascularized composite allografts. Curr Opin Organ Transplant (2017) 0.75
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Renal homotransplantation in identical twins. Surg Forum (1956) 3.19
Human hand allograft: report on first 6 months. Lancet (1999) 3.10
Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem (1998) 2.85
Study on transplantation immunity after total body irradiation: clinical and experimental investigation. Surgery (1960) 2.07
Three patients with full facial transplantation. N Engl J Med (2011) 2.05
Anti-HLA sensitization in extensively burned patients: extent, associated factors, and reduction in potential access to vascularized composite allotransplantation. Transpl Int (2015) 2.00
Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med (1979) 1.74
Successful transplantation of kidney from a human cadaver. JAMA (1963) 1.44
The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant (2008) 1.39
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit (1995) 1.28
Split tolerance to a composite tissue allograft in a swine model. Transplantation (2003) 1.18
Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med (2014) 1.14
Abdominal wall transplantation: surgical and immunologic aspects. Transplant Proc (2009) 1.12
First forearm transplantation: outcome at 3 years. Am J Transplant (2007) 1.10
CMV: Prevention, Diagnosis and Therapy. Am J Transplant (2013) 1.08
T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies. J Immunol (1982) 1.07
Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant (2006) 1.06
Graft vasculopathy in clinical hand transplantation. Am J Transplant (2012) 1.01
The effect of ischemia/reperfusion on the kidney graft. Curr Opin Organ Transplant (2014) 1.00
Vascularized composite allograft tolerance across MHC barriers in a large animal model. Am J Transplant (2014) 0.98
Uterus transplantation trial: 1-year outcome. Fertil Steril (2014) 0.97
Long-term follow-up in composite tissue allotransplantation: in-depth study of five (hand and face) recipients. Am J Transplant (2011) 0.97
Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation (2001) 0.97
Facial transplantation: the first 9 years. Lancet (2014) 0.96
The International Registry on Hand and Composite Tissue allotransplantation. Clin Transpl (2011) 0.96
Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg (1971) 0.93
The role of basiliximab induction therapy in organ transplantation. Expert Opin Biol Ther (2007) 0.91
Hand and upper extremity transplantation: an update of outcomes in the worldwide experience. Plast Reconstr Surg (2015) 0.91
Vascularized composite tissue allotransplantation--state of the art. Clin Transplant (2013) 0.90
The history of human composite tissue allotransplantation. Transplant Proc (2009) 0.89
Cytomegalovirus-related complications in human hand transplantation. Transplantation (2005) 0.89
Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. Am J Transplant (2009) 0.88
Improving peripheral nerve regeneration: from molecular mechanisms to potential therapeutic targets. Exp Neurol (2014) 0.87
Acute rejection in vascularized composite allotransplantation. Curr Opin Organ Transplant (2014) 0.86
T cells in organ ischemia reperfusion injury. Curr Opin Organ Transplant (2014) 0.85
A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft. Sci Transl Med (2014) 0.85
The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotransplant. Am J Transplant (2014) 0.83
Tongue transplantation. Lancet (2004) 0.82
Investigation of antibody-mediated rejection in composite tissue allotransplantation in a rat limb transplant model. Transplant Proc (2009) 0.82
Emerging therapies targeting intra-organ inflammation in transplantation. Am J Transplant (2015) 0.81
Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation. Front Immunol (2015) 0.81
Immunogenicity of glycerol-preserved human cadaver skin in vitro. J Burn Care Rehabil (1997) 0.80
Clinicopathological Findings of Chronic Rejection in a Face Grafted Patient. Transplantation (2015) 0.80
A simplified testing system to evaluate performance after transplantation of human skin preserved in glycerol or in liquid nitrogen. J Burn Care Rehabil (1993) 0.80
Changing paradigms in organ preservation and resuscitation. Curr Opin Organ Transplant (2015) 0.80
Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury. Mod Pathol (2014) 0.80
Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation. Transplantation (2013) 0.80
Antibody-mediated rejection in hand transplantation. Transpl Int (2013) 0.80
Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in renal transplant patient. Transplant Proc (1998) 0.80
CD3+-mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation (2009) 0.79
Vascularized composite allografts and solid organ transplants: similarities and differences. Curr Opin Organ Transplant (2013) 0.79
Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential. Clin Dev Immunol (2013) 0.79
Functional outcomes of face transplantation. Am J Transplant (2014) 0.79
Vascularized knee joint transplantation in man: a report on the first cases. Transpl Int (1998) 0.79
Thymoglobulin and its use in renal transplantation: a review. Am J Nephrol (2013) 0.79
Ethical issues in penile transplantation. Asian J Androl (2010) 0.78
Factors influencing acute rejection of human hand allografts: a systematic review. Ann Plast Surg (2012) 0.78
Achieving immune tolerance in hand and face transplantation: a realistic prospect? Immunotherapy (2014) 0.77
Transplantation of the larynx--a case report that speaks for itself. N Engl J Med (2001) 0.77
Alemtuzumab in solid organ transplantation and in composite tissue allotransplantation. Immunotherapy (2010) 0.77
Graft vasculopathy in the skin of a human hand allograft: implications for diagnosis of rejection of vascularized composite allografts. Transpl Int (2014) 0.77
Ischemia/reperfusion Injury and its Consequences on Immunity and Inflammation. Curr Transplant Rep (2014) 0.77
Effectiveness of topical immunosuppressants in prevention and treatment of rejection in face allotransplantation. Transplantation (2013) 0.77
Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation. Am J Transplant (2015) 0.77
Split rejection in vascularized composite allotransplantation. Eplasty (2013) 0.76
Recent advances in immunosuppressive therapy for prevention of renal allograft rejection. Curr Opin Organ Transplant (2011) 0.76
Immunosuppression and monitoring of rejection in hand transplantation. Tech Hand Up Extrem Surg (2013) 0.76
Spontaneous resolution of acute rejection and tolerance induction with IL-2 fusion protein in vascularized composite allotransplantation. Am J Transplant (2015) 0.76
Late nail lesions rejection in a stable bilateral forearm allograft at 60 months posttransplantation. Ann Plast Surg (2014) 0.76
Evolution of ethical debate on face transplantation. Plast Reconstr Surg (2013) 0.76
Utility of sentinel flaps in assessing facial allograft rejection. Plast Reconstr Surg (2015) 0.76
[Nerve transplantation and accompanying peripheral vessels for repair of long nerve defect]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2012) 0.76
Noninvasive Monitoring of Immune Rejection in Face Transplant Recipients. Plast Reconstr Surg (2015) 0.75